Ken Yamada
18Patents
1h-index
58Co-inventors
53Inventor score
Filing activity: Nov 5, 2008 → Nov 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11827882B2 | Modified oligonucleotides targeting SNPs | Chemistry; Metallurgy | 5 | Active |
| US11820985B2 | Modified oligonucleotides with increased stability | Chemistry; Metallurgy | 1 | Active |
| US10844055B2 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Chemistry; Metallurgy | 1 | Active |
| US8759365B2 | Organic compounds | Chemistry; Metallurgy | 0 | Active |
| US9867811B2 | Method of treating atherosclerosis in high triglyceride subjects | Human Necessities | 0 | Active |
| US12077758B2 | Oligonucleotides for SARS-CoV-2 modulation | Chemistry; Metallurgy | 0 | Active |
| US11609238B2 | Method for detecting a radical compound derived from a lipid and a compound derived from the radical compound | Chemistry; Metallurgy | 0 | Active |
| US12306164B2 | Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases | Physics | 0 | Active |
| US12024706B2 | Modified oligonucleotides targeting SNPs | Chemistry; Metallurgy | 0 | Active |
| US11725002B2 | Detection reagents and kit for identifying oxidized state and glycated state of low-density lipoproteins | Physics | 0 | Active |
| US12146136B2 | Synthesis of modified oligonucleotides with increased stability | Chemistry; Metallurgy | 0 | Active |
| US11530213B2 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Chemistry; Metallurgy | 0 | Active |
| US11767527B2 | Modified oligonucleotides targeting SNPs | General | 0 | Revoked |
| US10266531B2 | Naphthyridinone derivatives and their use in the treatment of arrhythmia | Chemistry; Metallurgy | 0 | Active |
| US8420641B2 | Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11519893B2 | Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseases | Physics | 0 | Active |
| US8440682B2 | 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8193349B2 | 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.